Brown Brothers Harriman & Co’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $616 | Buy |
30
+24
| +400% | +$549 | ﹤0.01% | 1778 |
|
|
2026
Q1 | $132 | Buy |
+6
| New | +$104 | ﹤0.01% | 1781 |
|
|
2025
Q3 | – | Sell |
-7
| Closed | -$80 | – | 1683 |
|
|
2025
Q2 | $80 | Sell |
7
-166
| -96% | -$1.87K | ﹤0.01% | 1537 |
|
|
2025
Q1 | $2.34K | Sell |
173
-4,973
| -97% | -$82.6K | ﹤0.01% | 1226 |
|
|
2024
Q4 | $87K | Hold |
5,146
| – | – | ﹤0.01% | 751 |
|
|
2024
Q3 | $105K | Sell |
5,146
-180
| -3% | -$3.68K | ﹤0.01% | 682 |
|
|
2024
Q2 | $120K | Buy |
5,326
+2
| +0% | +$52 | ﹤0.01% | 629 |
|
|
2024
Q1 | $140K | Sell |
5,324
-180
| -3% | -$5.13K | ﹤0.01% | 593 |
|
|
2023
Q4 | $174K | Hold |
5,504
| – | – | ﹤0.01% | 519 |
|
|
2023
Q3 | $154K | Hold |
5,504
| – | – | ﹤0.01% | 523 |
|
|
2023
Q2 | $203K | Buy |
5,504
+360
| +7% | +$11K | ﹤0.01% | 472 |
|
|
2023
Q1 | $154K | Hold |
5,144
| – | – | ﹤0.01% | 532 |
|
|
2022
Q4 | $158K | Sell |
5,144
-22
| -0.4% | -$660 | ﹤0.01% | 516 |
|
|
2022
Q3 | $127K | Hold |
5,166
| – | – | ﹤0.01% | 547 |
|
|
2022
Q2 | $165K | Hold |
5,166
| – | – | ﹤0.01% | 499 |
|
|
2022
Q1 | $163K | Hold |
5,166
| – | – | ﹤0.01% | 551 |
|
|
2021
Q4 | $173K | Hold |
5,166
| – | – | ﹤0.01% | 505 |
|
|
2021
Q3 | $150K | Hold |
5,166
| – | – | ﹤0.01% | 505 |
|
|
2021
Q2 | $180K | Hold |
5,166
| – | – | ﹤0.01% | 462 |
|
|
2021
Q1 | $144K | Hold |
5,166
| – | – | ﹤0.01% | 472 |
|
|
2020
Q4 | $128K | Sell |
5,166
-200
| -4% | -$4.76K | ﹤0.01% | 514 |
|
|
2020
Q3 | $112K | Sell |
5,366
-18
| -0.3% | -$347 | ﹤0.01% | 475 |
|
|
2020
Q2 | $83K | Hold |
5,384
| – | – | ﹤0.01% | 513 |
|
|
2020
Q1 | $48K | Hold |
5,384
| – | – | ﹤0.01% | 538 |
|
|
2019
Q4 | $97K | Buy |
5,384
+22
| +0.4% | +$365 | ﹤0.01% | 567 |
|
|
2019
Q3 | $80K | Hold |
5,362
| – | – | ﹤0.01% | 572 |
|
|
2019
Q2 | $129K | Sell |
5,362
-102
| -2% | -$3.01K | ﹤0.01% | 461 |
|
|
2019
Q1 | $203K | Sell |
5,464
-650
| -11% | -$23.7K | ﹤0.01% | 387 |
|
|
2018
Q4 | $173K | Hold |
6,114
| – | – | ﹤0.01% | 363 |
|
|
2018
Q3 | $241K | Buy |
6,114
+370
| +6% | +$16.2K | ﹤0.01% | 340 |
|
|
2018
Q2 | $255K | Sell |
5,744
-200
| -3% | -$9.95K | ﹤0.01% | 309 |
|
|
2018
Q1 | $290K | Sell |
5,944
-10
| -0.2% | -$500 | ﹤0.01% | 291 |
|
|
2017
Q4 | $298K | Buy |
5,954
+10
| +0.2% | +$524 | ﹤0.01% | 296 |
|
|
2017
Q3 | $301K | Hold |
5,944
| – | – | ﹤0.01% | 274 |
|
|
2017
Q2 | $225K | Buy |
5,944
+5,344
| +891% | +$211K | ﹤0.01% | 309 |
|
|
2017
Q1 | $23K | Sell |
600
-1,716
| -74% | -$51.6K | ﹤0.01% | 576 |
|
|
2016
Q4 | $51K | Hold |
2,316
| – | – | ﹤0.01% | 481 |
|
|
2016
Q3 | $37K | Sell |
2,316
-5,556
| -71% | -$63.5K | ﹤0.01% | 472 |
|
|
2016
Q2 | $65K | Buy |
7,872
+3,352
| +74% | +$29.9K | ﹤0.01% | 421 |
|
|
2016
Q1 | $32K | Sell |
4,520
-1,155
| -20% | -$5.8K | ﹤0.01% | 481 |
|
|
2015
Q4 | $30K | Sell |
5,675
-22,247
| -80% | -$142K | ﹤0.01% | 517 |
|
|
2015
Q3 | $181K | Buy |
+27,922
| New | +$292K | ﹤0.01% | 337 |
|
Other funds holding CC
CCPM
Brown Brothers Harriman & Co's CC Position: Q2 2026 in Review
Brown Brothers Harriman & Co increased its Chemours (CC) stake by 400% in Q2 2026, buying an estimated $549 and bringing the position to 30 shares worth $616. The position accounts for ﹤0.01% of the portfolio, ranked #1778.
Brown Brothers Harriman & Co first reported a position in CC in Q3 2015 and has held it in 42 quarters since. The position peaked at $301K in Q3 2017. 473 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Brown Brothers Harriman & Co held 30 shares of Chemours worth $616 as of Q2 2026.
- Brown Brothers Harriman & Co bought 24 Chemours shares in Q2 2026, an estimated $549.
- Chemours made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1778 holding.
- Brown Brothers Harriman & Co first reported a position in Chemours in Q3 2015 and has held it in 42 quarters since.
- Brown Brothers Harriman & Co's Chemours position peaked at $301K in Q3 2017.
- 473 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.